These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection. Lefeuvre A; Contamin H; Decelle T; Fournier C; Lang J; Deubel V; Marianneau P Microbes Infect; 2006 May; 8(6):1530-8. PubMed ID: 16697681 [TBL] [Abstract][Full Text] [Related]
23. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates. Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182 [TBL] [Abstract][Full Text] [Related]
24. Phenotypic analysis of yellow fever virus derived from complementary DNA. Marchevsky RS; Mariano J; Ferreira VS; Almeida E; Cerqueira MJ; Carvalho R; Pissurno JW; da Rosa AP; Simoes MC; Santos CN Am J Trop Med Hyg; 1995 Jan; 52(1):75-80. PubMed ID: 7856829 [TBL] [Abstract][Full Text] [Related]
25. Examination of the immunological relationships between flaviviruses using yellow fever virus monoclonal antibodies. Gould EA; Buckley A; Cammack N; Barrett AD; Clegg JC; Ishak R; Varma MG J Gen Virol; 1985 Jul; 66 ( Pt 7)():1369-82. PubMed ID: 2410549 [TBL] [Abstract][Full Text] [Related]
26. Characterization of a viscerotropic yellow fever vaccine variant from a patient in Brazil. Engel AR; Vasconcelos PF; McArthur MA; Barrett AD Vaccine; 2006 Apr; 24(15):2803-9. PubMed ID: 16464518 [TBL] [Abstract][Full Text] [Related]
27. Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213. dos Santos CN; Post PR; Carvalho R; Ferreira II; Rice CM; Galler R Virus Res; 1995 Jan; 35(1):35-41. PubMed ID: 7754673 [TBL] [Abstract][Full Text] [Related]
28. Neutralization of yellow fever virus studied using monoclonal and polyclonal antibodies. Buckley A; Gould EA J Gen Virol; 1985 Dec; 66 ( Pt 12)():2523-31. PubMed ID: 2999305 [TBL] [Abstract][Full Text] [Related]
30. Genetic variability among yellow fever virus 17D substrains. Galler R; Post PR; Santos CN; Ferreira II Vaccine; 1998; 16(9-10):1024-8. PubMed ID: 9682354 [TBL] [Abstract][Full Text] [Related]
31. Antibody-mediated early death in vivo after infection with yellow fever virus. Barrett AD; Gould EA J Gen Virol; 1986 Nov; 67 ( Pt 11)():2539-42. PubMed ID: 3783130 [TBL] [Abstract][Full Text] [Related]
32. Neurovirulence tests of three 17D yellow fever vaccine strains. Minor PD Biologicals; 2011 May; 39(3):167-70. PubMed ID: 21536454 [TBL] [Abstract][Full Text] [Related]
34. Biological characterization of plaque-size variants of yellow fever virus in mosquitoes and mice. Miller BR; Adkins D Acta Virol; 1988 May; 32(3):227-34. PubMed ID: 2902770 [TBL] [Abstract][Full Text] [Related]
35. The in vivo differentiation of strains of yellow fever virus in mice. Fitzgeorge R; Bradish CJ J Gen Virol; 1980 Jan; 46(1):1-13. PubMed ID: 6766176 [TBL] [Abstract][Full Text] [Related]
36. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine. Poland JD; Calisher CH; Monath TP; Downs WG; Murphy K Bull World Health Organ; 1981; 59(6):895-900. PubMed ID: 6978196 [TBL] [Abstract][Full Text] [Related]
37. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies. Barrett AD; Pryde A; Medlen AR; Ledger TN; Whitby JE; Gibson CA; DeSilva M; Groves DJ; Langley DJ; Minor PD Vaccine; 1989 Aug; 7(4):333-6. PubMed ID: 2479185 [TBL] [Abstract][Full Text] [Related]
38. Comparison of the nucleotide and deduced amino acid sequences of the envelope protein genes of the wild-type French viscerotropic strain of yellow fever virus and the live vaccine strain, French neurotropic vaccine, derived from it. Jennings AD; Whitby JE; Minor PD; Barrett AD Virology; 1993 Feb; 192(2):692-5. PubMed ID: 8421909 [TBL] [Abstract][Full Text] [Related]
39. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies. Ledger TN; Sil BK; Wills MR; Lewis G; Kinney RM; Jennings AD; Stephenson JR; Barrett AD Biologicals; 1992 Jun; 20(2):117-28. PubMed ID: 1389107 [TBL] [Abstract][Full Text] [Related]
40. Identification of envelope protein epitopes that are important in the attenuation process of wild-type yellow fever virus. Sil BK; Dunster LM; Ledger TN; Wills MR; Minor PD; Barrett AD J Virol; 1992 Jul; 66(7):4265-70. PubMed ID: 1376368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]